Biotech RadarJobs updated

COMPANY

Tavotek Biotherapeutics

tavotek.com ↗

Clinical Phase 2

Profile checked Oct 10, 2026

Keywords: Atopic Dermatitis TAVO412 TAVO101 TAVO103A

5Trials (company is sponsor)

Timeline

  1. Trial start Phase 2: A Study of TAVO101 in Atopic Dermatitis Patients source ↗
  2. Trial start Phase 1: A Study of TAVO412 in Patients with Cancer (TAVO412) source ↗
  3. Trial start Phase 1: A Study of TAVO412 in Patients with Cancer source ↗
  4. Trial start Phase 1: Study of TAVO101 in Healthy Volunteers source ↗
  5. Trial start Phase 1: Study of TAVO103A in Healthy Volunteers source ↗

Clinical trials (lead sponsor) 5

RecordTitlePhaseStatusStartPrimary completion
NCT06761651A Study of TAVO412 in Patients with Cancer (TAVO412)Phase 1RecruitingDec 20, 2023Jan 1, 2026 (estimated)
NCT05298046Study of TAVO101 in Healthy VolunteersPhase 1CompletedMay 11, 2022Jun 1, 2024 (actual)
NCT06176040A Study of TAVO101 in Atopic Dermatitis PatientsPhase 2Active, not recruitingMar 15, 2024Mar 15, 2025 (estimated)
NCT05548634A Study of TAVO412 in Patients with CancerPhase 1Active, not recruitingMay 8, 2023Dec 30, 2025 (estimated)
NCT05313152Study of TAVO103A in Healthy VolunteersPhase 1CompletedApr 5, 2022Apr 26, 2023 (actual)
Feedback